Ambu A/S (AMBFF)
- Simply Wall St.
Ambu And Two More Growth Leaders With High Insider Stakes
As global markets show signs of resilience with indices like the S&P 500 nearing record highs and the UK economy emerging from recession, investors are closely monitoring shifts in market dynamics and economic indicators. In this context, growth companies with high insider ownership can be particularly compelling, as significant insider stakes often signal confidence in the company's future prospects from those who know it best.
- GlobeNewswire
GRANT OF PERFORMANCE SHARE UNITS
Pursuant to Ambu A/S’ (Ambu) Remuneration Policy, a total of 172,956 Performance Share Units (PSUs) related to Ambu’s long-term incentive programme (LTIP) for 2023/24 have been granted on 6 February 2024 with retroactive effect from 1 January 2024. 49,109 of the PSUs have been granted to the Executive Management and 123,847 of the PSUs have been granted to other key employees. The LTIP covers the financial year 2023/24, and the final allocation of PSUs is conditional upon achievement of two key
- GlobeNewswire
INTERIM REPORT FOR Q1 2023/24
In Q1 2023/24, Ambu delivered 14% organic revenue growth and a 10.0% EBIT margin before special items. This was driven by Endoscopy Solutions growing 25%, due to continued high double-digit growth within urology and ENT, combined with pulmonology growing 18%. “I am pleased with the performance within the first quarter of the year, showcasing our continued commitment to delivering strong profitable growth. With 25% growth in Endoscopy Solutions, an increased profitability level and a positive fre
